Epidemiology of Candida kefyr in patients with hematologic malignancies. [PDF]
ABSTRACT Candida kefyr is an emerging pathogen among patients with hematologic malignancies (HM). We performed a retrospective study at Johns Hopkins Hospital to evaluate the epidemiology of C. kefyr colonization and infection in HM patients between 2004 and 2010.
Dufresne SF +9 more
europepmc +4 more sources
Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr. [PDF]
ABSTRACT Candida kefyr is an increasingly reported pathogen in patients with hematologic malignancies. We studied a series of bloodstream isolates that exhibited reduced echinocandin susceptibilities (RES). Clinical and surveillance isolates were tested for susceptibilities to all three echinocandins, and those ...
Staab JF +6 more
europepmc +4 more sources
Ізоляція та характеристика лактозоферментуючих дріжджів Candida kefyr [PDF]
Проведено скринінг лактозоферментуючих штамів дріжджів серед 162 штамів, ізольованих з різних рослин, та 28 штамів, виділених з сиру. Чотири штами дріжджів ферментували лактозу та були ідентифіковані як Candida kefyr.
Вороніна, Г.О. +2 more
core +2 more sources
Usefulness of Chromogenic Media in the Identification of Candida spp. Yeasts Compared to Mass Spectrometry [PDF]
Yeasts of the Candida genus are part of the normal human microbiota but can cause infections (candidiasis) under certain conditions. While Candida albicans remains the most common etiological agent, the prevalence of non-albicans Candida species—such as ...
Agata Bloch +3 more
doaj +2 more sources
In vitro analysis of postbiotic antimicrobial activity against Candida Species in a minimal synthetic model simulating the gut mycobiota in obesity [PDF]
Gut fungal imbalances, particularly increased Candida spp., are linked to obesity. This study explored the potential of Lactiplantibacillus plantarum cell-free extracts (postbiotics) to modulate the growth of Candida albicans and Candida kefyr, key ...
Ricardo García-Gamboa +5 more
doaj +2 more sources
Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. [PDF]
ABSTRACT Echinocandin drugs are widely used for the treatment of candidemia. Resistance is considered rare, and only a few cases of breakthrough candidiasis in patients receiving echinocandin have been reported worldwide. We report here for the first time a Candida kefyr isolate that acquired echinocandin ...
Fekkar A +9 more
europepmc +5 more sources
Kerion-Like Scalp Mycosis Caused by Candida kefyr [PDF]
No abstract available.
Pedaci, Fausto Andrea +4 more
openaire +2 more sources
A Cross-Sectional Study to Determine <i>Candida</i> spp. Carriage in Libyan Patients With Type 2 Diabetes. [PDF]
The risk for Candida infections in patients with diabetes mellitus (DM) is three times higher than in the general population. Despite a DM prevalence of 15.8% reported in Libya (2024), the laboratory identification and susceptibility testing of fungal infections in patients with DM are not routinely performed.
Esmaio MHM, Abrantes PMDS, Africa CWJ.
europepmc +2 more sources
Antifungal Resistance of Candida spp. Isolates From HIV/AIDS Patients in Iran 1999-2024: A Systematic Review and Meta-Analysis. [PDF]
Antimicrobial resistance in Candida spp. is significant in individuals with HIV/AIDS infections, particularly in Iran. In this systematic review, a comprehensive systematic search was conducted to identify all the eligible studies between 1999 and 2024; the pooled resistance rates of Candida spp. against antimicrobial agents were estimated. The risk of
Fakhri-Demeshghieh A +8 more
europepmc +2 more sources
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and ...
Patrick Schwarz +10 more
doaj +1 more source

